Incidence and Long‐Term Outcomes of Pouchitis in Ulcerative Colitis Patients
United European Gastroenterology Journal · 2025
DOI: 10.1002/ueg2.70089 ↗Kurz gefasst
Fachartikel in der Zeitschrift United European Gastroenterology Journal, 2025. Verfasst von Rosalina Bergstrøm und 8 weiteren Autor:innen. Beteiligte Einrichtung: Gastro Unit, Medical Section, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark. Hauptthemen laut MEDLINE: Pouchitis, Colitis, Ulcerative, Proctocolectomy, Restorative, Postoperative Complications. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Ileal pouch‐anal anastomosis (IPAA) is the preferred intervention for ulcerative colitis (UC) patients whose medical treatment fails. Acute severe ulcerative colitis (ASUC) can precipitate the need for urgent surgery, potentially influencing post‐IPAA outcomes.
Objective
This study details the incidence, disease course, and treatment of pouchitis and pouch failure in a population‐based cohort of UC patients following IPAA construction.
Methods
We included all UC patients who underwent IPAA construction within two administrative regions in Denmark between November 1993 and April 2021 in a population‐based cohort. Data spanning from diagnosis to January 2023 were manually extracted from electronic patient records and analyzed.
Results
Among 233 patients, 118 (50.6%) experienced 519 pouchitis events. 437 (84.2%) had intermittent pouchitis, 60 (11.6%) had chronic antibiotic‐dependent pouchitis, and 22 (4.2%) had chronic antibiotic‐refractory pouchitis. There was no significant difference in the incidence of pouchitis between patients who underwent urgent surgery due to ASUC and those who underwent non‐urgent surgery. Antibiotics were used in 89.6% of cases, with ciprofloxacin and metronidazole being the most common treatment. Thirty‐two (13.7%) patients experienced 36 pouch failures, 6.9% experienced permanent pouch failure, with 8.3% of failures attributed to pouchitis.
Conclusion
Half of the patients with IPAA experienced at least one episode of pouchitis. ASUC did not appear to increase the risk of pouchitis. The overall incidence of pouch failure was low, with pouchitis contributing to a minority of failures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastro Unit, Medical Section, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark.
- Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark.
- Gastro Unit, Surgical Section, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark.
- Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Rosalina Bergstrøm, Bobby Lo, Johan Burisch
Zitieren
APA
Bergstrøm, R., Lo, B., Toft, E., Schmidt, S., Kaiser, S., Kudernatsch, R., Bulut, O., Bendtsen, F., & Burisch, J. (2025). Incidence and Long‐Term Outcomes of Pouchitis in Ulcerative Colitis Patients. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70089
Vancouver
Bergstrøm R, Lo B, Toft E, Schmidt S, Kaiser S, Kudernatsch R, et al. Incidence and Long‐Term Outcomes of Pouchitis in Ulcerative Colitis Patients. United European Gastroenterology Journal. 2025. doi:10.1002/ueg2.70089
BibTeX
@article{Bergstrm2025,
author = {Bergstrøm, Rosalina and Lo, Bobby and Toft, Eva and Schmidt, Sebastian and Kaiser, Stephan and Kudernatsch, Robert and Bulut, Orhan and Bendtsen, Flemming and Burisch, Johan},
title = {Incidence and Long‐Term Outcomes of Pouchitis in Ulcerative Colitis Patients},
journal = {United European Gastroenterology Journal},
year = {2025},
doi = {10.1002/ueg2.70089}
}
EUVIMED